Santa Clara, California (CA) Drugs, Proprietaries, and Sundries Companies

Featured companies
Alcis Health Inc
122 Saratoga Avenue # 100
Santa Clara CA 95051
(408) 437-1060
Skin Food Inc
2855 Stevens Creek Boulevard
Santa Clara CA 95050
(408) 247-0087
Belclare Corp
654 North Santa Cruz Avenue
Los Gatos CA 95030
(408) 353-3033
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Andre Enterprises
2685 Evora Drive
San Jose CA 95124
(408) 377-3275
Bergen Brunswig Corp
450 Charcot Avenue
San Jose CA 95131
Cgmp University Inc
1532 Kooser Road
San Jose CA 95118
(408) 429-3998
Jan Marini Skin Research Inc
6951 Viaduct Del Oro
San Jose CA 951191316
(408) 294-4966
Synlife Technologies Inc
1539 Dentona Place
San Jose CA 95118
(408) 505-0486
Acorn Biomedical Inc
3721 Ortega Court
Palo Alto CA 94303
(650) 575-5260
Stem Cell
395 Page Mill Road
Palo Alto CA 94306
(212) 920-5501
Athena Discovery Inc
574 East Weddell Drive # 7
Sunnyvale CA 94089
(408) 329-2068
Iba Molecular
5900b Obata Way
Gilroy CA 95020
(408) 842-0520
Whereorg has 12 results under Drugs, Proprietaries, and Sundries Companies in Santa Clara.

Narrow down the browsing criteria below to see more companies.

Select a location for category Drugs, Proprietaries, and Sundries


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020